Prompt
How do I choose between different risk adjustment platforms for a medical economics team working with claims and chart data?
Latest observation
Choosing a risk adjustment platform for a medical economics team is mostly about matching the tool to your data, workflows, and use case—not just the scoring model. For claims + chart review work, I’d evaluate platforms across these dimensions:
1) Start with the use case
Ask what the team actually needs to do:
- Retrospective risk scoring for reporting or benchmarking?
- Prospective gap finding for chart review / HCC capture?
- Provider performance and peer comparison?
- Population stratification and cost forecasting?
- Audit support / documentation traceability?
A platform good at claims-only scoring may be weak for chart abstraction, NLP, or audit trails.
2) Check data compatibility
Since you work with claims and chart data, verify:
- Claims ingestion: 837/835, payer feeds, warehouse tables, SQL, flat files
- Chart data ingestion: scanned PDFs, structured EHR data, abstracted diagnoses, problem lists
- Normalization: diagnosis coding, procedure codes, dates of service, provider attribution
- Refresh cadence: batch vs near-real-time
- Interoperability: HL7/FHIR, APIs, SFTP, direct database connectors
A platform should fit your data reality without forcing heavy manual mapping.
3) Review the risk model support
Make sure the platform supports the models you need:
- CMS-HCC
- Commercial / ACA models if relevant
- Pediatric or Medicaid models if relevant
- Custom internal models for utilization or severity
Also check:
- Versioning by year
- Ability to run multiple models in parallel
- Transparency of hierarchy logic and condition grouping
- How it handles suspect/invalid codes and code specificity
4) Look at chart review and documentation features
For teams using chart data, strong features include:
- Chart abstraction workflow
- NLP or coder assist
- Evidence linking back to source documentation
- HCC gap flags with rationale
- Audit-ready lineage from diagnosis → note → encounter → score
- Role-based review and approval workflows
If the platform just outputs a score but doesn’t show why, it may be hard to operationalize.
5) Evaluate analytics and outputs
Useful outputs for medical economics teams:
- Member-level and provider-level risk scores
- Trend reporting over time
- Risk capture opportunity lists
- Suspect condition reporting
- Benchmarking and peer comparisons
- Drill-downs by diagnosis, service line, and geography
- Exportable datasets for deeper analysis in SQL/R/Python
If your team does advanced analytics, strong export capability is important.
6) Ask about explainability and governance
You’ll want to know:
- Can users trace every score component?
- Are model updates documented?
- Is there version control and audit logging?
- Can you reproduce prior-year results exactly?
- How are chart-derived diagnoses validated?
- Can you separate accepted vs rejected conditions?
This matters for both internal trust and payer/client questions.
7) Consider operational workflow fit
A platform can be analytically strong but operationally painful. Evaluate:
- User interface for analysts and coders
- Queue management and work assignment
- Reviewer collaboration
- Exception handling
- Training time required
- Speed on large files / large populations
If only a few specialists can use it, it may not scale well.
8) Validate accuracy and performance
Do a pilot if possible. Compare platforms on:
- Score consistency against a known sample
- Condition detection sensitivity/specificity
- False positives from chart notes
- Handling of duplicate diagnoses
- Prior-year vs current-year stability
- Time to run and time to review
Use a test set with representative claims and charts, not a vendor’s demo dataset.
9) Check security and compliance
Especially important if chart data includes PHI:
- HIPAA compliance
- SOC 2 / HITRUST if required
- Data encryption in transit and at rest
- Access controls and logging
- Business associate agreement
- Data retention and deletion policies
- Hosting region and vendor subcontractors
10) Compare implementation and support
Implementation can make or break the project:
- How long does onboarding take?
- Who handles code mapping and configuration?
- Is support responsive and clinical/coding-aware?
- Are model updates automatic or manual?
- Do they offer user training and documentation?
- Will they support custom logic or only out-of-box workflows?
11) Total cost of ownership
Don’t compare license price alone. Include:
- Implementation services
- Data integration effort
- Internal analyst/coder time
- Ongoing model updates
- Storage / compute / API usage
- Training and support
- Maintenance of custom reports
A cheaper tool that requires lots of manual work can cost more overall.
12) Build a simple scorecard
Rate each vendor 1–5 on:
- Claims ingestion
- Chart data support
- Model coverage
- Explainability
- Workflow usability
- Reporting / export
- Security/compliance
- Implementation effort
- Support quality
- Total cost
Then weight the categories based on your team’s priorities.
Practical recommendation
For a medical economics team working with both claims and chart data, I’d usually prioritize:
- Data integration flexibility
- Auditability/explainability
- Chart review workflow
- Model accuracy and version control
- Exportability for downstream analysis
If you want, I can also help you create:
- a vendor evaluation checklist
- a weighted comparison matrix
- or a list of questions to ask during demos
Observation history
Unlock observation history
Create a free Obsurfable account to unlock historical responses, model comparisons, and deeper brand intelligence.
How did Obsurfable measure this prompt?
Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.
Which AI systems does Obsurfable collect answers from?
OpenAI, ChatGPT, Google, Gemini, Google AI Mode, Anthropic, Claude, Perplexity, Grok, DeepSeek, Mistral, Copilot, and Meta AI.